Data / Research funding / Pennsylvania / Integral Molecular
Integral Molecular: 15 NIH awards ($17.8M), fiscal years 2021 to 2026
Integral Molecular in Philadelphia, PA is funded under 15 NIH awards ($17.8M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- DY9KSWE8EJB8
- State
- Pennsylvania
Awards
15 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| B cell Epitope Discovery and Mechanisms of Antibody Protection for Enterovirus and Bunyavirus Entry Proteins | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $3,291,808 | September 16, 2024 | September 15, 2026 | reporter.nih.gov | |
| B-Cell Epitope Discovery and Mechanisms of Antibody Protection for ZIKV, MARV, VEEV Envelope Proteins | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,133,973 | September 16, 2019 | September 15, 2024 | DORANZ, BENJAMIN | reporter.nih.gov |
| Specificity Screening Drug Development Tool for Biotherapeutic Safety | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $1,846,470 | September 1, 2024 | August 31, 2027 | DORANZ, BENJAMIN J | reporter.nih.gov |
| Development of Claudin MAbs for Treating Solid Tumors | NIH | National Cancer Institute | 2022 to 2024 | $1,703,866 | June 1, 2022 | November 30, 2024 | RUCKER, JOSEPH BENJAMIN | reporter.nih.gov |
| ANTIBODY REAGENTS FOR IMMUNOLOGIC ANALYSIS OF UNDER-REPRESENTED MAMMALIAN MODELS | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,500,000 | June 1, 2025 | May 31, 2028 | CHAMBERS, ROSS | reporter.nih.gov |
| Development of Kv1.3 Monoclonal Antibodies Targeting TEM Cells for Treating Autoimmune Disorders | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $1,223,786 | September 5, 2014 | September 30, 2024 | RUCKER, JOSEPH BENJAMIN | reporter.nih.gov |
| High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA | NIH | National Institute of General Medical Sciences | 2025 | $923,143 | May 1, 2023 | January 31, 2028 | CHAMBERS, ROSS S | reporter.nih.gov |
| Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $706,380 | February 1, 2015 | December 31, 2023 | DORANZ, BENJAMIN J | reporter.nih.gov |
| ADJUVANT TARGET DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES. | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $600,000 | June 30, 2022 | June 29, 2024 | RUCKER, JOSEPH | reporter.nih.gov |
| Reagents for Immunologic Analysis of Under-represented Mammalian Models | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $600,000 | September 1, 2023 | August 31, 2025 | CHAMBERS, ROSS | reporter.nih.gov |
| Development of Safe and Rapid Reporter Viruses for Studying Pathogenic and Pandemic Viruses | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $577,030 | July 1, 2024 | June 30, 2026 | DORANZ, BENJAMIN J | reporter.nih.gov |
| Generation of Pan-reactive Antibody and Cytokine Reagents for Immunologic Analysis of Bats | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $495,061 | August 19, 2025 | June 30, 2030 | CHAMBERS, ROSS S | reporter.nih.gov |
| Development of Nav1.7 Monoclonal Antibodies for Treating Pain | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $474,833 | September 20, 2021 | August 31, 2023 | RUCKER, JOSEPH BENJAMIN | reporter.nih.gov |
| Identifying Regulators of Cellular Aging that can Prevent Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2023 | $447,566 | June 1, 2022 | November 30, 2024 | DORANZ, BENJAMIN J | reporter.nih.gov |
| High-throughput Discovery of Antibodies against Understudied Membrane Proteins | NIH | National Institute of General Medical Sciences | 2023 | $295,924 | May 1, 2023 | April 30, 2024 | CHAMBERS, ROSS S | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 6 | $5,858,060 | 0 | $0 |
| 2024 | 4 | $3,170,173 | 0 | $0 |
| 2023 | 5 | $2,754,683 | 0 | $0 |
| 2022 | 6 | $3,396,484 | 0 | $0 |
| 2021 | 4 | $2,640,440 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Biotechnology
- Immunization
- Emerging Infectious Diseases
- Infectious Diseases
- Biodefense and Related Countermeasures
- Immunotherapy
- Neurosciences
- Rare Diseases
- Prevention
- Autoimmune Disease
- Brain Disorders
- Vector-Borne Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.